insights from industryNatalie Strickland Global Head of Translational ScienceSynexa Life Sciences In this interview, News Medical speaks with Natalie Strickland, Global Head of Translational Science ...

Lateral flow assays (LFAs, often called "dipsticks") have been a standard point-of-care testing platform for decades, and keep growing in popularity, especially in developing countries. These ...

Choosing assays for pharmaceutical screening is often a compromise between using the ideal target biologies and the harsh realities of reagent availability and cost. This is especially acute during ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Please could you both introduce yourselves and give a brief outline of your roles at Cerba Research? ADB: My name is Ans De Beuckelaer. I have a Ph.D. in biotechnology from the University of Ghent. In ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

New serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens MINNEAPOLIS, Oct. 19, 2020 /PRNewswire/ ...

Diagnostic testing has become an essential aspect in a wide variety of settings. Testing assists in the identification of risk factors such as cholesterol levels for coronary disease risk.

SAN FRANCISCO, Nov. 27, 2025 /PRNewswire/ -- The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to 2033, according to a ...